These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 22961090

  • 1. Leflunomide: friend or foe for systemic lupus erythematosus?
    Wu GC, Xu XD, Huang Q, Wu H.
    Rheumatol Int; 2013 Feb; 33(2):273-6. PubMed ID: 22961090
    [Abstract] [Full Text] [Related]

  • 2. The beneficial effect of leflunomide on systemic lupus erythematosus: the role of Tregs repopulation?: Comment on: Leflunomide: friend or foe for systemic lupus erythematosus? Rheumatol Int 2013, 33(2):273-6.
    Shin JI.
    Rheumatol Int; 2014 Jun; 34(6):881. PubMed ID: 23765200
    [No Abstract] [Full Text] [Related]

  • 3. [Leflunomide in systemic lupus erythematosus].
    Kessel A, Toubi E.
    Harefuah; 2002 Apr; 141(4):355-7, 409. PubMed ID: 12017890
    [Abstract] [Full Text] [Related]

  • 4. Leflunomide for the treatment of systemic lupus erythematosus: comment on the article by McMurray.
    Barthel HR.
    Arthritis Rheum; 2001 Oct; 45(5):472. PubMed ID: 11642648
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of changes in joint function and peripheral blood mononuclear cells in patients with systemic lupus erythematosus and intervention effects of different drugs.
    Zhou QS, Hu J, Hu H.
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4423-4430. PubMed ID: 29077150
    [Abstract] [Full Text] [Related]

  • 6. Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.
    Tam LS, Li EK, Wong CK, Lam CW, Szeto CC.
    Lupus; 2004 Oct; 13(8):601-4. PubMed ID: 15462490
    [Abstract] [Full Text] [Related]

  • 7. [Collagen diseases and rheumatic diseases].
    Takeuchi T, Amano K, Tsuzake K, Kameda H, Abe T.
    Nihon Naika Gakkai Zasshi; 2004 Mar 10; 93(3):538-44. PubMed ID: 15052817
    [No Abstract] [Full Text] [Related]

  • 8. Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions.
    Marzano AV, Ramoni S, Del Papa N, Barbareschi M, Alessi E.
    Lupus; 2008 Apr 10; 17(4):329-31. PubMed ID: 18413415
    [Abstract] [Full Text] [Related]

  • 9. How to treat refractory arthritis in lupus?
    Artifoni M, Puéchal X.
    Joint Bone Spine; 2012 Jul 10; 79(4):347-50. PubMed ID: 22341583
    [Abstract] [Full Text] [Related]

  • 10. Leflunomide: A safe and effective alternative in systemic lupus erythematosus.
    Carrión-Barberà I, Polino L, Mejía-Torres M, Pérez-García C, Ciria M, Pros A, Rodríguez-García E, Monfort J, Salman-Monte TC.
    Autoimmun Rev; 2022 Feb 10; 21(2):102960. PubMed ID: 34560304
    [No Abstract] [Full Text] [Related]

  • 11. [Leflunomide--a new drug for pharmacological immunomodulation].
    Wozel G, Pfeiffer C.
    Hautarzt; 2002 May 10; 53(5):309-15. PubMed ID: 12063741
    [Abstract] [Full Text] [Related]

  • 12. Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.
    Remer CF, Weisman MH, Wallace DJ.
    Lupus; 2001 May 10; 10(7):480-3. PubMed ID: 11480845
    [Abstract] [Full Text] [Related]

  • 13. Leflunomide.
    Cannon GW, Kremer JM.
    Rheum Dis Clin North Am; 2004 May 10; 30(2):295-309, vi. PubMed ID: 15172042
    [Abstract] [Full Text] [Related]

  • 14. Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus.
    Dong GF, Zhang X, He DN, Li L, Zhang GF.
    J Immunol Res; 2015 May 10; 2015():832916. PubMed ID: 26090500
    [Abstract] [Full Text] [Related]

  • 15. Benefit/risk of leflunomide in rheumatoid arthritis.
    Kremer JM, Cannon GW.
    Clin Exp Rheumatol; 2004 May 10; 22(5 Suppl 35):S95-100. PubMed ID: 15552521
    [Abstract] [Full Text] [Related]

  • 16. Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.
    Popovic S, Bartlett RR.
    Agents Actions; 1986 Dec 10; 19(5-6):313-4. PubMed ID: 3825747
    [No Abstract] [Full Text] [Related]

  • 17. Rheumatoid arthritis and the Arava (leflunomide) controversy.
    Turkoski BB.
    Orthop Nurs; 2003 Dec 10; 22(1):48-51. PubMed ID: 12640952
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of leflunomide in active rheumatoid arthritis.
    Smolen JS, Emery P.
    Rheumatology (Oxford); 2000 Jun 10; 39 Suppl 1():48-56. PubMed ID: 11001380
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of leflunomide therapy in lupus nephritis by repeat kidney biopsy.
    Zhang FS, Nie YK, Jin XM, Yu HM, Li YN, Sun Y.
    Rheumatol Int; 2009 Sep 10; 29(11):1331-5. PubMed ID: 19169882
    [Abstract] [Full Text] [Related]

  • 20. The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery.
    Popovic S, Bartlett RR.
    Agents Actions; 1987 Aug 10; 21(3-4):284-6. PubMed ID: 3687582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.